Genmab A-S

Genmab A-S

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$26.10
Previous Close
$25.94
Day Range
$25.83-$26.22
52W Range
$20.22-$35.43
Market Cap
$15.7B
Shares Short
10M

Financials

See more
Revenue (12 Mos)
$3.9B
Revenue Growth (YoY)
25.3%
Gross Profit (12 Mos)
$3.6B
Diluted EPS
$1.31

News

See more

Yahoo Finance • 8 days ago

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Yahoo Finance • 9 days ago

Genmab’s EPCORE Data Deepens Lymphoma Profile As Investors Weigh Upside

Yahoo Finance • 11 days ago

Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Yahoo Finance • 13 days ago

Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Across Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Patients

About

CEO
Dr. Jan G.J. van de Winkel Ph.D.
CFO
Mr. Anthony Pagano CPA
Address
Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
3,088